Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients ; volume:15 ; number:1 ; day:14 ; month:4 ; year:2014 ; pages:1-7 ; date:12.2014
BMC pharmacology & toxicology ; 15, Heft 1 (14.4.2014), 1-7, 12.2014
- Creator
-
Goncalves-Pereira, João
- Contributor
-
Silva, Nuno Elvas
Mateus, André
Pinho, Catarina
Póvoa, Pedro
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-15-21
- URN
-
urn:nbn:de:1111-2016071828268
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Goncalves-Pereira, João
- Silva, Nuno Elvas
- Mateus, André
- Pinho, Catarina
- Póvoa, Pedro
- SpringerLink (Online service)
Other Objects (12)
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
BK viremia in critically ill surgical patients with hemorrhagic or septic shock
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Population pharmacokinetics of meropenem in critically ill patients
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
Surgical treatment of spondylodiscitis in critically ill septic patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Endoscopic guide wire gallbladder decompression in a critically ill, septic patient
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
BK viremia in critically ill surgical patients with hemorrhagic or septic shock